Cargando…

Community-based survey to assess seroprevalence of poliovirus antibodies in far-north Cameroon in 2020

BACKGROUND: This study assessed seroprevalence of poliovirus antibodies in children from selected poliovirus high-risk areas of the Far North region of Cameroon which serves to monitor polio immunization program. METHODS: This was a community-based cross-sectional seroprevalence survey involving col...

Descripción completa

Detalles Bibliográficos
Autores principales:	Claire Endegue, Marie, Sein, Carolyn, Lopez Cavestany, Rocio, Jeyaseelan, Visalakshi, Palmer, Tess, Norbert Soke, Gnakub, Diaha, Aissata, Jafri, Basit, Mainou, Bernardo A., Verma, Harish, Mach, Ondrej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Regular paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763508/ https://www.ncbi.nlm.nih.gov/pubmed/36560978 http://dx.doi.org/10.1016/j.jvacx.2022.100244

Ejemplares similares

A Survey to Assess Serological Prevalence of Poliovirus Antibodies in Areas With High-Risk for Vaccine-Derived Poliovirus Transmission in Chad
por: Gamougam, Kadidja, et al.
Publicado: (2021)

Achieving High Poliovirus Antibody Seroprevalence in Areas at Risk of Vaccine-Derived Poliovirus Transmission—Niger Experience
por: Ousmane, Sani, et al.
Publicado: (2021)

Inactivated Poliovirus Vaccine Closing the Type 2 Immunity Gap in Vietnam
por: Huyen, Dang Thi Thanh, et al.
Publicado: (2022)

Poliovirus antibodies following two rounds of campaigns with a type 2 novel oral poliovirus vaccine in Liberia: a clustered, population-based seroprevalence survey
por: Kennedy, Stephen B, et al.
Publicado: (2023)

One Full or Two Fractional Doses of Inactivated Poliovirus Vaccine for Catch-up Vaccination in Older Infants: A Randomized Clinical Trial in Bangladesh( )
por: Aziz, Asma B, et al.
Publicado: (2022)

Assessment of poliovirus antibody seroprevalence in high risk areas for vaccine derived poliovirus transmission in Madagascar
por: Razafindratsimandresy, Richter, et al.
Publicado: (2018)

Detection and characterization of polioviruses originating from urban sewage in Yaounde and Douala, Cameroon 2016–2017
por: Njile, Daniel Kamga, et al.
Publicado: (2019)

Immunogenicity of Reduced-Dose Monovalent Type 2 Oral Poliovirus Vaccine in Mocuba, Mozambique
por: de Deus, Nilsa, et al.
Publicado: (2020)

Achieving high immunogenicity against poliovirus with fractional doses of inactivated poliovirus vaccine in Ecuador-results from a cross-sectional serological survey
por: Trueba, Gabriel, et al.
Publicado: (2022)

Poliovirus seroprevalence before and after interruption of poliovirus transmission in Kano State, Nigeria
por: Iliyasu, Zubairu, et al.
Publicado: (2016)

Randomized Controlled Clinical Trial of Bivalent Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine in Nigerian Children
por: Tagbo, Beckie N, et al.
Publicado: (2020)

Achieving high seroprevalence against polioviruses in Sri Lanka-Results from a serological survey, 2014
por: Gamage, Deepa, et al.
Publicado: (2015)

Intradermal administration of fractional doses of the inactivated poliovirus vaccine in a campaign: a pragmatic, open-label, non-inferiority trial in The Gambia
por: Bashorun, Adedapo O, et al.
Publicado: (2021)

Trends in Poliovirus Seroprevalence in Kano State, Northern Nigeria
por: Verma, Harish, et al.
Publicado: (2018)

Seroprevalence rate of Poliovirus antibodies among the Healthy and Protein Energy Malnutrition children
por: Yousuf, Aliya, et al.
Publicado: (2015)

Review of use of inactivated poliovirus vaccine in campaigns to control type 2 circulating vaccine derived poliovirus (cVDPV) outbreaks()
por: Estivariz, Concepcion F., et al.
Publicado: (2023)

Decay of Sabin inactivated poliovirus vaccine (IPV)-boosted poliovirus antibodies
por: Resik, Sonia, et al.
Publicado: (2015)

Does Simultaneous Administration of Bivalent (Types 1 and 3) Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine Induce Mucosal Cross-immunity to Poliovirus Type 2?
por: Resik, Sonia, et al.
Publicado: (2018)

Seroprevalence of Poliovirus Antibodies in the United States Population, 2009–2010
por: Wallace, Gregory S., et al.
Publicado: (2016)

Assessment of seroprevalence against poliovirus among Italian adolescents and adults
por: Lupi, Silvia, et al.
Publicado: (2018)

Immunogenicity of Fractional Dose Inactivated Poliovirus Vaccine in India
por: Ahmad, Mohammad, et al.
Publicado: (2021)

Poliomyelitis seroprevalence in high risk populations of India before the trivalent-bivalent oral poliovirus vaccine switch in 2016
por: Ahmad, Mohammad, et al.
Publicado: (2021)

Immunogenicity of two-dose and three-dose vaccination schedules with Sabin inactivated poliovirus vaccine in China: An open-label, randomized, controlled trial
por: Wang, Yamin, et al.
Publicado: (2021)

Poliovirus excretion following vaccination with live poliovirus vaccine in patients with primary immunodeficiency disorders: clinicians’ perspectives in the endgame plan for polio eradication
por: Galal, Nermeen M., et al.
Publicado: (2018)

Is Italian population protected from Poliovirus? Results of a seroprevalence survey in Florence, Italy
por: Giammanco, Giovanni M., et al.
Publicado: (2018)

Prolonged Excretion of Poliovirus among Individuals with Primary Immunodeficiency Disorder: An Analysis of the World Health Organization Registry
por: Macklin, Grace, et al.
Publicado: (2017)

Poliovirus excretion among children with primary immune deficiency in Pakistan: a pilot surveillance study protocol
por: Pethani, Asma Sadruddin, et al.
Publicado: (2021)

Seroprevalence of Toxoplasma gondii infection among pregnant women in Cameroon
por: Njunda, Anna L., et al.
Publicado: (2011)

Genetic landscape and macro-evolution of co-circulating Coxsackieviruses A and Vaccine-derived Polioviruses in the Democratic Republic of Congo, 2008-2013
por: Sadeuh-Mba, Serge Alain, et al.
Publicado: (2019)

Succeeding in New Vaccine Introduction: Lessons Learned From the Introduction of Inactivated Poliovirus Vaccine in Cameroon, Kenya, and Nigeria
por: Scotney, Soleine, et al.
Publicado: (2017)

Update on Immunodeficiency-Associated Vaccine-Derived Polioviruses — Worldwide, July 2018–December 2019
por: Macklin, Grace, et al.
Publicado: (2020)

Sexual vulnerability and HIV seroprevalence among the deaf and hearing impaired in Cameroon
por: Touko, Adonis, et al.
Publicado: (2010)

Seroprevalence of Gestational and Neonatal Toxoplasmosis as well as Risk Factors in Yaoundé, Cameroon
por: Ayeah, Joy Nkain, et al.
Publicado: (2022)

Immunogenicity of poliovirus vaccines in chronically malnourished infants: A randomized controlled trial in Pakistan
por: Saleem, Ali Faisal, et al.
Publicado: (2015)

Needle adapters for intradermal administration of fractional dose of inactivated poliovirus vaccine: Evaluation of immunogenicity and programmatic feasibility in Pakistan
por: Saleem, Ali Faisal, et al.
Publicado: (2017)

A telephone based assessment of the health situation in the far north region of Cameroon
por: Gignoux, Etienne Marc Hugues, et al.
Publicado: (2020)

Feasibility of conducting intradermal vaccination campaign with inactivated poliovirus vaccine using Tropis intradermal needle free injection system, Karachi, Pakistan
por: Yousafzai, Mohammad Tahir, et al.
Publicado: (2017)

Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with monovalent vaccine: a retrospective analysis of surveillance data for 51 countries in Africa
por: Cooper, Laura V, et al.
Publicado: (2022)

Seroprevalence study of hepatitis A virus in Fars province, southern Iran
por: Taghavi, Seyed Alireza, et al.
Publicado: (2011)

Seroprevalence of cystic echinococcosis in blood donors in Fars province, southern Iran
por: Sarkari, Bahador, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6iim1114ncnrnj29e0ig8k6bjp